Intravitreal triamcinolone will, more often than not, lead to the development of cataracts in eyes with diabetic macular oedema (DME), according to the results of a study published in the March 17, 2006 issue of Eye.
RhyGaze announces $86 million in Series A financing for optogentic vision restoration therapy candidate
The company, which has European headquarters in Basel, Switzerland, plans to use the funds for a non-interventional, observational study and a first-in-human clinical trial
Higher Molar Dose and Its Translation into Clinical Practice
Teva partners with Klinge Biopharma for commercialisation of Formycon’s FYB203 (biosimilar aflibercept)
The commercialisation agreement for the biosimilar to aflibercept (Eylea) covers Israel and major parts of Europe, excluding Italy
Bausch + Lomb launches its enVista Aspire monofocal and toric intraocular lenses in the European Union
The launch follows a CE Mark received in late 2024
Study explores possible applications of retinal imaging in schizophrenia detection
The study built on previous research indicating specific retinal variables can serve as disease-related biomarkers in neurodegenerative diseases
Retinopathy of prematurity study demonstrates noninferiority of combination microdrops compared to standard mydriatics
The authors investigated systemic adverse events associated with commercial mydriatics administered during retinopathy of prematurity (ROP) screening